Skip to main content
. 2012 Dec 20;7(12):e52643. doi: 10.1371/journal.pone.0052643

Table 1. Caracteristics of the study subject at baseline surveya.

Male Pre-menopausal female Post-menopausal female
N 146 99 212
Age (y) 57.1 (8.9) 44.8 (5.3) 60.5 (5.8)
Body height (cm) 165.8 (6.5) 155.4 (4.9) 151.9 (5.7)
Body weight (kg) 64.9 (8.7) 54.9 (9.7) 50.9 (7.4)
Body mass index (kg/m2) 23.6 (2.7) 22.7 (3.9) 22.0 (2.8)
Total energy intake (kcal/day)
Including ethanol 2157.4 (473.8) 1913.7 (437.5) 1940.5 (443.2)
Excluding ethanol 2017.7 (452.2) 1898.2 (441.6) 1928.0 (443.1)
Calcium intake (mg/day) 521.3 (219.3) 584.6 (190.8) 642.1 (232.2)
Potassium intake (mg/day) 2481.0 (824.5) 2512.2 (774.2) 2871.1 (860.7)
Magnesium intake (mg/day) 270.3 (72.5) 244.5 (66.1) 278.4 (72.6)
Vitamin C intake (mg/day)b 126.3 (115.3–138.4) 115.4 (104.7–127.2) 170.6 (161.0–180.8)
Vitamin D intake (µg/day)b 4.9 (4.4–5.5) 5.1 (4.5–5.7) 6.3 (5.8–6.8)
Vitamin E intake (mg/day)b 7.4 (7.0–7.9) 7.6 (7.2–8.1) 8.0 (7.7–8.3)
Serum carotenoid concentrations (µmol/L)b
Lutein 0.45 (0.43–0.47) 0.47 (0.44–0.50) 0.56 (0.53–0.58)
Lycopene 0.31 (0.28–0.33) 0.46 (0.42–0.50) 0.38 (0.35–0.40)
α-Carotene 0.13 (0.12–0.14) 0.20 (0.18–0.22) 0.22 (0.20–0.24)
β-Carotene 0.58 (0.53–0.65) 0.90 (0.81–1.01) 1.16 (1.09–1.24)
β-Cryptoxanthn 1.26 (1.09–1.45) 1.05 (0.91–1.22) 1.80 (1.64–1.98)
Zeaxanthin 0.19 (0.18–0.20) 0.20 (0.19–0.21) 0.21 (0.20–0.21)
Current tobacco use (%) 25.3 2.0 1.9
Exercise habits (%)c 21.2 14.1 17.9
Regular alcohol intake (%)c 58.9 16.2 13.2
Current supplement use (%) 3.4 14.1 9.0
a

Data are mean (standard deviation), geometric mean (95% confidence interval), range, or percent.

b

These variables were represented as original scale after analysis by log (natural) transformed values.

c

> = 1 times/wk.